Vascular Access Devices Market: By Product (Central Catheters, Peripheral Catheters, Accessories), By Application (Transfusion of Blood Products, Diagnostic Testing, Medication Administration), By Route of Insertion (Subcutaneous, Intravenous), By End User (Hospitals, Ambulatory Surgery Centers, Others), and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Vascular access devices market size was valued at USD 3.88 billion in 2022 and is projected to reach USD 6.17 billion by 2029, growing at a CAGR of 6.8% from 2023 to 2029. Vascular access is a method of introducing or removing devices or chemicals from the bloodstream. Vascular access devices (VADs) are medical devices that are inserted into veins via peripheral or central vessels for diagnostic or therapeutic reasons, such as blood sampling, central venous pressure readings, administration of medication, fluids, total parenteral nutrition (TPN), and blood transfusions. One of the primary forces fueling the growth of the global market is technological improvements in the field of vascular access devices. The Global Vascular Access Devices Market research offers a comprehensive analysis of the industry. The research includes a detailed analysis of key segments, trends, drivers, constraints, the competitive landscape, and other important market variables. Central venous pressure readings, fluids, blood sampling, total parental nourishment, blood transfusion, and medicine administration are examples of diagnostic instruments. Through peripheral vessels, these devices are introduced into veins. Because of advances in diagnostics, treatments, and therapies, the demand for vascular access devices is growing. The vascular access devices offer the capacity to mix a solution containing nutritional components without causing complications.

Vascular Access Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.8%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Vascular Access Devices Market Dynamics

Increase in the prevalence of the chronic disorders such as obesity, cardiac disorders, and diabetes are the key factors attributing the growth of the vascular access devices. Growing incidence of the kidney disorders is adding fuel for the growth of the market. The changing lifestyles resulting in various health related issues are driving the growth off the market. The technological advancements in the field of vascular access is anticipating the growth of the market. The growing government initiatives is further adding scope for the growth of the vascular access devices. However, the high cost associated with treatment is hampering the growth of the vascular access devices market.

Vascular Access Devices Market Segmentation

By Product Type

Central Catheters

  • Hemodialysis Catheters
  • Implantable Ports
  • Peripherally Inserted Central Catheters (PICC)
  • Central Venous Catheters (CVC)

2. Peripheral Catheters

  • Peripheral Intravenous Catheters (PIVC)
  • Midline Catheters

3. Accessories

By Application
  • Transfusion of Blood Products
  • Diagnostic Testing
  • Medication Administration
By Route of Insertion
  • Subcutaneous
  • Intravenous
By End-User
  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Frequently Asked Questions

The vascular access devices market size was valued at USD 3.88 billion in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The vascular access devices market key players are: Becton, Dickinson & Company (U.S.), Medtronic (U.S.), Revolutions Medical Corporation (U.S.), Retractable Technologies, Inc. (U.S.), Royal Imtech N.V. (Smiths Medical) (Netherlands, Terumo Corporation (Japan), Unilife Corporation (U.S.), Sol-Millennium Medical Group (China), Ultimed, Inc. (U.S.), Axel Bio Corporation (U.S.)

Key Features of the Reports

  • The vascular Access devices market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Vascular Access Devices Market Introduction 
2.1.Global Vascular Access Devices Market  - Taxonomy
2.2.Global Vascular Access Devices Market  - Definitions
2.2.1.Product
2.2.2.Application
2.2.3.Route of Insertion
2.2.4.End User
2.2.5.Region
3.Global Vascular Access Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Vascular Access Devices Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Vascular Access Devices Market  By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Central Catheters
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Peripheral Catheters
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Accessorie
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Vascular Access Devices Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Transfusion of Blood Products
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnostic Testing
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Medication Administration
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Vascular Access Devices Market  By Route of Insertion, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Subcutaneous
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Intravenous
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Vascular Access Devices Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Ambulatory Surgery Centers
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Others
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Vascular Access Devices Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Central Catheters
10.1.2.Peripheral Catheters
10.1.3.Accessorie
10.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Transfusion of Blood Products
10.2.2.Diagnostic Testing
10.2.3.Medication Administration
10.3.  Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Subcutaneous
10.3.2.Intravenous
10.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Ambulatory Surgery Centers
10.4.3.Others
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Central Catheters
11.1.2.Peripheral Catheters
11.1.3.Accessorie
11.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Transfusion of Blood Products
11.2.2.Diagnostic Testing
11.2.3.Medication Administration
11.3.  Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Subcutaneous
11.3.2.Intravenous
11.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Ambulatory Surgery Centers
11.4.3.Others
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Central Catheters
12.1.2.Peripheral Catheters
12.1.3.Accessorie
12.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Transfusion of Blood Products
12.2.2.Diagnostic Testing
12.2.3.Medication Administration
12.3.  Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Subcutaneous
12.3.2.Intravenous
12.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Ambulatory Surgery Centers
12.4.3.Others
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Central Catheters
13.1.2.Peripheral Catheters
13.1.3.Accessorie
13.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Transfusion of Blood Products
13.2.2.Diagnostic Testing
13.2.3.Medication Administration
13.3.  Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Subcutaneous
13.3.2.Intravenous
13.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Ambulatory Surgery Centers
13.4.3.Others
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Central Catheters
14.1.2.Peripheral Catheters
14.1.3.Accessorie
14.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Transfusion of Blood Products
14.2.2.Diagnostic Testing
14.2.3.Medication Administration
14.3.  Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Subcutaneous
14.3.2.Intravenous
14.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Ambulatory Surgery Centers
14.4.3.Others
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Becton, Dickinson & Company (U.S.)
15.2.2.Medtronic (U.S.)
15.2.3.Revolutions Medical Corporation (U.S.)
15.2.4.Retractable Technologies, Inc. (U.S.)
15.2.5.Royal Imtech N.V. (Smiths Medical)
15.2.6 Terumo Corporation (Japan)
15.2.7.Unilife Corporation (U.S.)
15.2.8 Sol-Millennium Medical Group (China)
15.2.9.Ultimed, Inc. (U.S.)
15.2.10.Axel Bio Corporation (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Becton, Dickinson & Company (U.S.)
  • Medtronic (U.S.)
  • Revolutions Medical Corporation (U.S.)
  • Retractable Technologies, Inc. (U.S.)
  • Royal Imtech N.V. (Smiths Medical) (Netherlands
  • Terumo Corporation (Japan)
  • Unilife Corporation (U.S.)
  • Sol-Millennium Medical Group (China)
  • Ultimed, Inc. (U.S.)
  • Axel Bio Corporation (U.S.)

Adjacent Markets